HK-CRISPR-Nup188-mEGFP
Cell line · Product number 300657
HK-CRISPR-Nup188-mEGFP is a genetically modified Hela Kyoto cell line. It uses CRISPR/Cas9 technology to integrate mEGFP (monomeric Enhanced Green Fluores...
Recommended (freshest lot)
01General information
- Description
HK-CRISPR-Nup188-mEGFP 是一种转基因的 Hela Kyoto 细胞系。它利用 CRISPR/Cas9 技术在 Nup188 基因座上整合了 mEGFP(单体增强型绿色荧光蛋白)。Nup188 是一种参与核孔复合体的关键核蛋白,对细胞核和细胞质之间的分子运输至关重要。通过 mEGFP 标记可以实时观察 Nup188,有助于研究核孔复合体的动态和功能。
这种细胞系对研究核转运和核孔复合体生物学的人员特别有用。它的荧光标记能在各种条件下观察 Nup188,包括药物治疗和基因修饰。其应用包括高内涵筛选、活细胞成像和其他基于荧光的技术,为了解核胞质转运和核包膜完整性提供了宝贵的信息。
- Tissue
- 宫颈内口
- Disease
- 腺癌
- Metastatic site
- 不适用(HeLa京都衍生物;原发肿瘤部位为宫颈管)
- Applications
- 核孔复合体(NPC)生物学;核-细胞质转运;Nup188的动力学与功能;核膜的活细胞荧光成像;高通量筛选;CRISPR敲入验证研究;核转运抑制剂评估
02Classification
- Organism
- Human
- Sex
- Female
- Growth properties
- Adherent
- GMO status
- GMO-S1
- GMO status details
- GMO-S1: This HeLa Kyoto line contains a CRISPR knock-in of mEGFP at the Nup188 locus, enabling visualization of nuclear pore scaffold dynamics. This classification applies only within Germany and may differ elsewhere.
- Biosafety level
- 1
03Characteristics
- Morphology
- 具有镶嵌石形状的上皮样细胞
- Cell type
- 上皮细胞
04Identifiers
- Citation
- HK-CRISPR-Nup188-mEGFP(Cytion 目录号 300657)
- NCBI TaxID
- 9606
- Depositor
- 艾伦伯格实验室(EMBL)
05Expression and susceptibility
- Protein expression
- Nup188,mEGFP-标记
06Handling and culture
- Culture medium
- DMEM,w:4.5 克/升葡萄糖,w:4 毫摩尔 L-谷氨酰胺,w:3.7 克/升 NaHCO3,w:1.0 毫摩尔丙酮酸钠(Cytion 编号 820300a)。
- Incubation atmosphere
37°C, 5%CO2, 加湿环境。
- Supplements
- 在培养基中添加 10% FBS
- Dissociation reagent
- Accutase
- Subculturing
- 去除粘附细胞上的旧培养基,用不含钙和镁的 PBS 冲洗。T25 烧瓶用 3-5 毫升 PBS,T75 烧瓶用 5-10 毫升。然后用 Accutase 完全覆盖细胞,T25 烧瓶用 1-2 毫升,T75 烧瓶用 2.5 毫升。让细胞在室温下孵育 8-10 分钟,使其分离。孵育后,用 10 毫升培养基轻轻混合细胞使其重悬,然后用 300xg 离心 3 分钟。弃去上清液,用新鲜培养基重悬细胞,并将其转移到已装有新鲜培养基的新烧瓶中。
- Thawing and culturing
Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.
Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.
For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.
Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.
Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.
Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.
Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.
Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.
07Quality control and cryopreservation
- Sterility
使用基于 PCR 的检测方法和基于发光的支原体检测方法排除支原体污染。
为确保没有细菌、真菌或酵母菌污染,每天都要对细胞培养物进行目视检查。
- Freeze medium
- 我们使用完全生长培养基(包括 FBS)+10% DMSO 或 CM-1(Cytion 商品目录编号 800100)作为冷冻保存培养基,以获得足够的解冻后存活率,CM-1(Cytion 商品目录编号 800100)含有优化的渗透保护剂和代谢稳定剂,可提高恢复能力并减少冷冻引起的应激。
- Storage conditions
如需长期保存,可将样品瓶放入气相液氮中,温度约为 -150 至 -196 ℃。在-80 °C下保存只能作为转入液氮前的短暂过渡。
- Shipping conditions
冷冻保存的细胞系用干冰装运,并用经过验证的隔热包装和足够的制冷剂在整个运输过程中保持约 -78 °C 的温度。收到货后,应立即检查容器,并立即将小瓶转移到适当的储藏室。
08Donor
- Donor age
- 30年
- Ethnicity
- 非洲裔美国人
09Legal and safety
- Safety precautions
- 计划将低温样品储存在液氮中以便将来解冻时,必须遵守严格的安全措施。在将冷冻样本移入或移出液氮罐时,必须穿戴适当的防护手套和防护服,并使用面罩或安全护目镜。这样做是为了降低在移出时因冷冻样品爆炸而造成伤害的风险,因为爆炸可能导致锋利的碎片飞溅。
- Warranty
在Cytion,我们保证产品的质量和活力。 我们保证,从我们的工厂发货后 60 天内,我们的细胞在开始培养时都是存活的。 我们保证所有材料均符合分析证书和/或产品说明书中描述的规格。
有关详细信息,请参阅我们的 <a href="" /Who-we-are/Warranty/"" hreflang=""x-default"">保修声明 。
- Third-party agreements apply
- Yes
.jpg)